跳至主要内容
临床试验/CTRI/2023/11/059765
CTRI/2023/11/059765招募中4 期

Comparison of the analgesic efficacy of combined peri-articular hypertonic dextrose prolotherapy, intra-articular Magnesium and Ozone (Dextrose Magnesium Ozone Therapy) with Intra articular Corticosteroid in the management of moderate-severe Osteoarthritis of the Knee: Randomized Double-Blind, Placebo-controlled Trial - NI

Sri Madhusudan Sai Institute of Medical Sciences and Research,0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult patients aged 40 years and above, who meet the American College of Rheumatology criteria for osteoarthritis (knee pain for most of the days of the previous month and osteophyte (s) at the joint line visible on X ray) 29, are willing to consent and have moderate-severe OAK.
  • Clinical Severity: Patients should have a mean score of 1.5 - 3.5 on WOMAC A sub score30, 31.
  • Radiological Severity of Osteoarthritis of the knee is based on the criteria defined by Kellgren and Lawrence, which grades OAK into 0-4 grades32. This study will be including Grade 3 and Grade 4 Osteoarthritis of the knee

排除标准

  • Participants unwilling to provide consent
  • Patients with mild OAK
  • Participants with known history of drug allergy to bupivacaine, corticosteroid or lidocaine
  • Patients on anticoagulant or antiplatelet medication
  • Patients who have had a myocardial infraction in the last 6 months
  • Patients with secondary OAK (gout, RA, Psoriasis) or generalized osteoarthritis
  • Patients who have received intra articular steroids into any joint within 3 months

研究者

发起方
Sri Madhusudan Sai Institute of Medical Sciences and Research,

相似试验

Prolozone Therapy for Osteoarthritis of the Knee... | 临床试验